Clinical Drug Trials
New medical treatments go through rigorous testing before they are approved for general use. In the final stages of this approval process, suitable patients are invited to take part in trials of these new drugs.
Helen Rollason Cancer Charity supports research trials to develop new cancer drugs and treatments.
Our team of Helen Rollason research nurses provides care for cancer patients on these clinical drug trials at Broomfield Hospital in Essex and North Middlesex University Hospital in London. These patients are able to access treatments which may be licensed but are not yet available on the NHS, are awaiting NICE approval or are a novel new agent.
Since 2000, Helen Rollason research nurses have supported over 3,000 cancer patients in Essex and London, resulting in effective new treatments that are now available to the general public.
We manage the largest Cancer Research Clinical Drug Trial Programme in the Essex Hospitals Network. In 2011, the Helen Rollason Research Centre was opened at Broomfield Hospital to enable more patients to participate.
For more information on clinical drugs trials, please refer to our ‘Frequently asked questions’ page.